SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as community excitement surges following Conditional Marketing Authorisation for ANKTIVA in Europe, coupled with high anticipation for broader approvals and substantial investment from a strategic Saudi-USA Biotech Alliance, igniting strong anti-short sentiment.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amidst heightened volatility and polarized sentiment, as community concerns over housing affordability, the disruptive economic impact of AI, and geopolitical tensions in the Middle East fuel a contentious debate between those expecting further downside and contrarians anticipating a rebound.

Pull your BankrWallet out of the Terminal and into the browser to use with Any Dapp, just like Metamask!

BankrWallet

BNKRW is trending with high community interest and volume, driven by the launch of its open-source BankrWallet browser extension, which offers MetaMask-like functionality within the Coinbase BASE ecosystem. Investors are actively discussing its significant upside potential as they anticipate upcoming developer catalysts.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending ahead of its pivotal Phase 3 superiority trial results for Axpaxli in wet AMD, set for release Tuesday, with the community highly optimistic about a potential "landslide victory" and a significant short squeeze amidst circulating rumors of a sweetened acquisition offer from Sanofi.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is rallying after reporting strong Q4 earnings and announcing a $50 million share repurchase program, further supported by strategic tailwinds from rising RAM prices and a competitor exiting the retail memory market. The community is actively discussing its potential for a short squeeze and highlighting the stock's perceived undervaluation.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending as activist investor Elliott Management reveals a significant stake, fueling community discussion about potential changes and the recent CEO transition, while many question controversial analyst downgrades for a stock that has lagged its cruise sector rivals.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened community debate, with many predicting a deeper correction for large-cap tech as AI disruption fears intensify
including a major AI firm being designated a "supply chain risk"
while others suggest current valuations are oversold and poised for a rebound. Traders are closely watching key technical support levels and upcoming economic catalysts that could define the market's next move.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending amidst a fierce debate between bulls, who believe the semiconductor sector remains unstoppable due to the massive AI infrastructure buildout and influential political backing, and bears, who highlight the ETF's repeated struggle at the $70 mark as a potential "triple top" indicating stretched valuations and an impending pullback.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is a major talking point as investors eagerly await a 'transformational' acquisition, heavily rumored following CEO Ryan Cohen's cryptic hints and recent reports of notable investors like Michael Burry increasing their positions. The community remains focused on potential market-altering moves and persistent claims of short seller vulnerability, maintaining a strong 'diamond hands' sentiment.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is currently a battleground for investors, with widespread frustration over its sustained price decline and perceived lack of management communication, while a segment of the community sees it as a deeply undervalued long-term opportunity, highlighted by recent institutional filings and a new market data feed for overnight trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings...

Esperion Therapeutics (NASDAQ:ESPR) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen downgraded Esperion Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Zacks Research Issues Optimistic Forecast for ESPR Earnings

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Analysts at Zacks Research upped their Q4 2025 earnings estimates for Esperion Therapeutics in a research report issued on Tuesday, February...

Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen

Wall Street Zen raised Esperion Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell?

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell...

What is HC Wainwright's Estimate for ESPR FY2025 Earnings?

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Stock analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Esperion Therapeutics in a note issued to investors...

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - Should You Buy...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ESPR News

ESPREsperion Therapeutics Inc.